148 related articles for article (PubMed ID: 31252588)
1. New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction.
Dalos D; Spinka G; Schneider M; Wernly B; Paar V; Hoppe U; Litschauer B; Strametz-Juranek J; Sponder M
J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252588
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
[TBL] [Abstract][Full Text] [Related]
3. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
[TBL] [Abstract][Full Text] [Related]
5. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.
Jirak P; Pistulli R; Lichtenauer M; Wernly B; Paar V; Motloch LJ; Rezar R; Jung C; Hoppe UC; Schulze PC; Kretzschmar D; Braun-Dullaeus RC; Bekfani T
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32326570
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
8. A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15.
Kletzer J; Hecht S; Ramsauer S; Scharinger B; Kaufmann R; Kammler J; Kellermair J; Akbari K; Blessberger H; Steinwender C; Hergan K; Hoppe UC; Lichtenauer M; Boxhammer E
J Cardiovasc Dev Dis; 2023 Jan; 10(1):. PubMed ID: 36661917
[TBL] [Abstract][Full Text] [Related]
9. Serum heart-type fatty acid-binding protein decreases and soluble isoform of suppression of tumorigenicity 2 increases significantly by long-term physical activity.
Sponder M; Lichtenauer M; Wernly B; Paar V; Hoppe U; Emich M; Fritzer-Szekeres M; Litschauer B; Strametz-Juranek J
J Investig Med; 2019 Jun; 67(5):833-840. PubMed ID: 30593542
[TBL] [Abstract][Full Text] [Related]
10. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
11. The Discriminatory Ability of Renalase and Biomarkers of Cardiac Remodeling for the Prediction of Ischemia in Chronic Heart Failure Patients With the Regard to the Ejection Fraction.
Stojanovic D; Mitic V; Stojanovic M; Petrovic D; Ignjatovic A; Milojkovic M; Dunjic O; Milenkovic J; Bojanic V; Deljanin Ilic M
Front Cardiovasc Med; 2021; 8():691513. PubMed ID: 34395559
[No Abstract] [Full Text] [Related]
12. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
13. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
14. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease.
Wang J; Han LN; Ai DS; Wang XY; Zhang WJ; Xu XR; Liu HB; Zhang J; Wang P; Li X; Chen ML
J Geriatr Cardiol; 2023 Jul; 20(7):527-537. PubMed ID: 37576485
[TBL] [Abstract][Full Text] [Related]
16. Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity.
Baessler A; Strack C; Rousseva E; Wagner F; Bruxmeier J; Schmiedel M; Riegger G; Lahmann C; Loew T; Schmitz G; Fischer M
Eur J Heart Fail; 2012 Nov; 14(11):1240-8. PubMed ID: 22843563
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease.
Persson M; Östling G; Smith G; Hamrefors V; Melander O; Hedblad B; Engström G
Stroke; 2014 Jan; 45(1):18-23. PubMed ID: 24253546
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
20. Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study.
Mirna M; Topf A; Wernly B; Rezar R; Paar V; Jung C; Salmhofer H; Kopp K; Hoppe UC; Schulze PC; Kretzschmar D; Schneider MP; Schultheiss UT; Sommerer C; Paul K; Wolf G; Lichtenauer M; Busch M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32213894
[No Abstract] [Full Text] [Related]
[Next] [New Search]